The EGF receptor family comprises several related receptor tyrosine kinases that are frequently overexpressed in a variety of carcinomas. Upregulation of EGFR is associated with tumor progression. Abrogation of EGFR may be achieved with the use of EGFR Inhibitors with potential results in cell cycle arrest, apoptosis or dedifferentiation of cancer cells. EGFR Substrates offered by Santa Cruz affects EGFR and, in some cases, other receptor tyrosine kinases and tumor progression related proteins. View detailed EGFR Substrate specifications, including EGFR Substrate CAS number, molecular weight, molecular formula and chemical structure, by clicking on the product name.
|PRODUCT NAME/Application||CAS||Catalog #||QUANTITY||Price||Citations||RATING|
|pp60v-src Autophosphorylation Site, Tyrosine Kinase Substrate is a tyrosine kinase substrate with ability to phosphorylate||81493-98-3||
0.5 mg/0.1 ml
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.